Share Price and Basic Stock Data
Last Updated: November 20, 2025, 9:35 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
BL Kashyap & Sons Ltd operates in the construction, contracting, and engineering sector, showcasing a market capitalization of ₹1,128 Cr with its current stock price at ₹50.1. The company has experienced fluctuations in revenue, reporting sales of ₹1,110 Cr for the fiscal year ending March 2023, which declined from ₹1,158 Cr in March 2022. However, the trailing twelve months (TTM) revenue stood at ₹1,228 Cr, indicating a recovery trend. Quarterly sales figures reveal variability, with the highest recorded in September 2023 at ₹327 Cr and a decline to ₹253 Cr in June 2023. The revenue trajectory reflects a seasonal pattern, with expectations of increased activity in upcoming quarters, particularly as the company anticipates a sales rise to ₹350 Cr in June 2024. The construction sector in India typically sees growth driven by government infrastructure initiatives, which could provide a favorable backdrop for BL Kashyap’s operations.
Profitability and Efficiency Metrics
The profitability of BL Kashyap & Sons has shown mixed results, with an operating profit margin (OPM) of 8% as of the most recent reporting. The operating profit for the fiscal year 2025 is projected at ₹65 Cr, down from ₹110 Cr in 2024. Net profit figures have fluctuated, with a reported loss of ₹32 Cr in March 2023, while the latest quarterly net profit in June 2025 recorded at ₹11 Cr. This inconsistency is reflected in the return on equity (ROE) of just 2% and return on capital employed (ROCE) standing at 8.08%, which are low compared to industry standards for construction firms, typically around 10-15%. The cash conversion cycle is 113 days, indicating a relatively high time to convert investments into cash, which may affect liquidity. The company’s ability to manage costs effectively and improve operational efficiency will be crucial for enhancing profitability going forward.
Balance Sheet Strength and Financial Ratios
BL Kashyap’s balance sheet reveals a cautious approach to leverage, with total borrowings reported as ₹0 Cr, resulting in a long-term debt-to-equity ratio of 0.07, which is favorable compared to industry norms. The interest coverage ratio (ICR) stands at 1.93, indicating that the company can cover its interest obligations comfortably, although still below the ideal threshold of 2.0. The price-to-book value (P/BV) ratio is 2.21x, suggesting that the market values the company’s equity at a premium compared to its book value, which stood at ₹23.23 per share. Additionally, the current ratio of 1.40 and quick ratio of 1.17 indicate adequate short-term liquidity, although they are at the lower end of the acceptable range for the construction sector. Overall, while the company maintains a healthy balance sheet, its profitability metrics and operational efficiency require improvement to enhance overall financial health.
Shareholding Pattern and Investor Confidence
The shareholding pattern of BL Kashyap & Sons indicates strong promoter control, with promoters holding 61.70% of the company as of June 2025. This reflects a stable ownership structure, which can instill confidence among investors. The foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold minor stakes at 0.34% and 0.59%, respectively, which suggests limited institutional interest. The public shareholding stands at 37.37%, with a notable increase in the number of shareholders from 24,602 in March 2023 to 44,066 in June 2025, indicating growing retail investor interest. However, the low institutional ownership may raise concerns about the stock’s liquidity and long-term stability. The steady increase in public shareholders could be a positive sign of market confidence, but the company needs to attract more institutional investment to enhance its credibility and support stock performance.
Outlook, Risks, and Final Insight
The outlook for BL Kashyap & Sons appears cautiously optimistic, supported by the TTM revenue growth and a recovery in profitability metrics. However, several risks persist. The company’s operating profit margin remains low, and fluctuations in net profit may deter potential investors. Additionally, the high cash conversion cycle of 113 days could strain liquidity, especially in a capital-intensive industry like construction. On the strength side, the absence of debt provides financial flexibility, and promoter commitment signifies stability. The company must focus on improving operational efficiency and profitability to bolster investor confidence. A strategic approach towards enhancing project execution and cost management will be vital for sustainable growth. Should the company successfully navigate these challenges, it could position itself favorably within the competitive landscape of the Indian construction sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of BL Kashyap & Sons Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modis Navnirman Ltd | 742 Cr. | 381 | 409/220 | 90.4 | 46.5 | 0.00 % | 12.9 % | 9.88 % | 10.0 |
| Modulex Construction Technologies Ltd | 173 Cr. | 25.0 | 35.7/18.0 | 44.7 | 0.00 % | 2.51 % | 1.54 % | 10.0 | |
| MPDL Ltd | 35.2 Cr. | 47.5 | 92.7/38.0 | 127 | 0.00 % | 2.87 % | 4.16 % | 10.0 | |
| IITL Projects Ltd | 25.9 Cr. | 52.0 | 78.1/45.6 | 2.12 | 0.00 % | 16.6 % | % | 10.0 | |
| HB Estate Developers Ltd | 184 Cr. | 80.2 | 122/69.9 | 16.7 | 81.0 | 0.00 % | 8.20 % | 6.60 % | 10.0 |
| Industry Average | 17,282.10 Cr | 255.45 | 82.38 | 139.97 | 0.15% | 16.62% | 21.24% | 21.58 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 289 | 293 | 253 | 276 | 253 | 327 | 324 | 341 | 350 | 267 | 242 | 294 | 336 |
| Expenses | 257 | 272 | 231 | 253 | 228 | 298 | 300 | 308 | 319 | 247 | 236 | 287 | 310 |
| Operating Profit | 32 | 21 | 22 | 23 | 25 | 29 | 24 | 33 | 32 | 20 | 6 | 7 | 26 |
| OPM % | 11% | 7% | 9% | 8% | 10% | 9% | 7% | 10% | 9% | 8% | 3% | 2% | 8% |
| Other Income | 0 | 5 | 9 | -30 | 3 | 1 | 1 | 8 | 9 | 12 | 9 | 15 | 3 |
| Interest | 13 | 13 | 12 | 13 | 11 | 11 | 12 | 15 | 11 | 14 | 10 | 12 | 11 |
| Depreciation | 3 | 3 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 17 | 11 | 16 | -23 | 14 | 17 | 10 | 22 | 27 | 15 | 2 | 7 | 15 |
| Tax % | 30% | 45% | -129% | 41% | 28% | 29% | 31% | -6% | 24% | 38% | 41% | 149% | 26% |
| Net Profit | 12 | 6 | 37 | -32 | 10 | 12 | 7 | 24 | 20 | 9 | 1 | -3 | 11 |
| EPS in Rs | 0.52 | 0.25 | 1.62 | -1.42 | 0.44 | 0.53 | 0.31 | 1.05 | 0.90 | 0.42 | 0.05 | -0.14 | 0.48 |
Last Updated: August 19, 2025, 10:50 pm
Below is a detailed analysis of the quarterly data for BL Kashyap & Sons Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 336.00 Cr.. The value appears strong and on an upward trend. It has increased from 294.00 Cr. (Mar 2025) to 336.00 Cr., marking an increase of 42.00 Cr..
- For Expenses, as of Jun 2025, the value is 310.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 287.00 Cr. (Mar 2025) to 310.00 Cr., marking an increase of 23.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 19.00 Cr..
- For OPM %, as of Jun 2025, the value is 8.00%. The value appears strong and on an upward trend. It has increased from 2.00% (Mar 2025) to 8.00%, marking an increase of 6.00%.
- For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 12.00 Cr..
- For Interest, as of Jun 2025, the value is 11.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12.00 Cr. (Mar 2025) to 11.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 8.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 149.00% (Mar 2025) to 26.00%, marking a decrease of 123.00%.
- For Net Profit, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from -3.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 14.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.48. The value appears strong and on an upward trend. It has increased from -0.14 (Mar 2025) to 0.48, marking an increase of 0.62.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:51 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,349 | 834 | 860 | 924 | 1,012 | 769 | 820 | 762 | 1,158 | 1,110 | 1,245 | 1,154 | 1,228 |
| Expenses | 1,296 | 816 | 792 | 834 | 927 | 713 | 799 | 699 | 1,067 | 1,012 | 1,134 | 1,088 | 1,168 |
| Operating Profit | 53 | 19 | 68 | 89 | 85 | 57 | 21 | 63 | 90 | 98 | 110 | 65 | 60 |
| OPM % | 4% | 2% | 8% | 10% | 8% | 7% | 3% | 8% | 8% | 9% | 9% | 6% | 5% |
| Other Income | -65 | 31 | 23 | 0 | 31 | 5 | -22 | 7 | 41 | -16 | 12 | 45 | 28 |
| Interest | 97 | 81 | 82 | 83 | 77 | 59 | 69 | 59 | 55 | 51 | 49 | 47 | 44 |
| Depreciation | 23 | 47 | 21 | 13 | 12 | 12 | 12 | 11 | 10 | 10 | 10 | 12 | 14 |
| Profit before tax | -132 | -78 | -12 | -6 | 27 | -10 | -82 | -1 | 66 | 21 | 63 | 50 | 31 |
| Tax % | -36% | -26% | -48% | -181% | 23% | -34% | -23% | 8,490% | 33% | -7% | 17% | 45% | |
| Net Profit | -85 | -58 | -6 | 5 | 21 | -6 | -63 | -58 | 44 | 22 | 53 | 27 | 0 |
| EPS in Rs | -4.14 | -2.82 | -0.29 | 0.24 | 0.98 | -0.28 | -2.79 | -2.59 | 1.95 | 0.98 | 2.33 | 1.22 | 0.01 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 31.76% | 89.66% | 183.33% | 320.00% | -128.57% | -950.00% | 7.94% | 175.86% | -50.00% | 140.91% | -49.06% |
| Change in YoY Net Profit Growth (%) | 0.00% | 57.89% | 93.68% | 136.67% | -448.57% | -821.43% | 957.94% | 167.93% | -225.86% | 190.91% | -189.97% |
BL Kashyap & Sons Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 7% |
| 3 Years: | 0% |
| TTM: | -15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 22% |
| 3 Years: | -2% |
| TTM: | -72% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 55% |
| 3 Years: | 39% |
| 1 Year: | -35% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 6% |
| 3 Years: | 8% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 2:31 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 107 | 169 | 187 | 156 | 127 | 176 | 171 | 210 | 110 | 138 | 111 | 138 |
| Inventory Days | 259 | 414 | 384 | 333 | 261 | 372 | 347 | 201 | 240 | 105 | 130 | |
| Days Payable | 150 | 188 | 163 | 118 | 152 | 170 | 179 | 116 | 140 | 136 | 154 | |
| Cash Conversion Cycle | 215 | 396 | 407 | 371 | 236 | 378 | 339 | 210 | 195 | 238 | 80 | 113 |
| Working Capital Days | 37 | 73 | 94 | 13 | -19 | -7 | 41 | 84 | 41 | 64 | 68 | 94 |
| ROCE % | 4% | 0% | 6% | 7% | 9% | 5% | 2% | 8% | 10% | 14% | 14% | 8% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 1.22 | 2.33 | 0.98 | 1.95 | -2.59 |
| Diluted EPS (Rs.) | 1.22 | 2.33 | 0.98 | 1.95 | -2.59 |
| Cash EPS (Rs.) | 1.77 | 2.79 | 1.41 | 2.41 | -2.10 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 23.23 | 22.02 | 19.73 | 18.76 | 16.82 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 23.23 | 22.02 | 19.73 | 18.76 | 16.82 |
| Revenue From Operations / Share (Rs.) | 51.17 | 55.20 | 49.24 | 51.34 | 33.81 |
| PBDIT / Share (Rs.) | 4.06 | 5.43 | 5.22 | 4.10 | 3.90 |
| PBIT / Share (Rs.) | 3.51 | 4.97 | 4.79 | 3.64 | 3.41 |
| PBT / Share (Rs.) | 2.23 | 2.81 | 0.91 | 2.92 | -0.03 |
| Net Profit / Share (Rs.) | 1.22 | 2.33 | 0.98 | 1.95 | -2.59 |
| NP After MI And SOA / Share (Rs.) | 1.22 | 2.33 | 0.98 | 1.95 | -2.59 |
| PBDIT Margin (%) | 7.92 | 9.84 | 10.60 | 7.99 | 11.54 |
| PBIT Margin (%) | 6.85 | 9.00 | 9.72 | 7.09 | 10.09 |
| PBT Margin (%) | 4.35 | 5.08 | 1.85 | 5.69 | -0.08 |
| Net Profit Margin (%) | 2.38 | 4.22 | 1.99 | 3.79 | -7.66 |
| NP After MI And SOA Margin (%) | 2.38 | 4.22 | 1.99 | 3.79 | -7.66 |
| Return on Networth / Equity (%) | 5.24 | 10.58 | 4.97 | 10.39 | -15.40 |
| Return on Capital Employeed (%) | 11.60 | 17.16 | 18.33 | 12.39 | 10.79 |
| Return On Assets (%) | 1.81 | 3.72 | 1.70 | 3.06 | -3.84 |
| Long Term Debt / Equity (X) | 0.07 | 0.06 | 0.08 | 0.15 | 0.29 |
| Total Debt / Equity (X) | 0.60 | 0.62 | 0.71 | 0.86 | 1.11 |
| Asset Turnover Ratio (%) | 0.78 | 0.91 | 0.81 | 0.76 | 0.44 |
| Current Ratio (X) | 1.40 | 1.37 | 1.36 | 1.21 | 1.27 |
| Quick Ratio (X) | 1.17 | 0.71 | 0.87 | 0.77 | 0.82 |
| Inventory Turnover Ratio (X) | 1.59 | 1.57 | 1.55 | 1.84 | 1.14 |
| Interest Coverage Ratio (X) | 1.93 | 2.51 | 2.29 | 1.69 | 1.48 |
| Interest Coverage Ratio (Post Tax) (X) | 1.19 | 2.08 | 2.13 | 1.10 | 0.32 |
| Enterprise Value (Cr.) | 1439.17 | 1822.80 | 959.52 | 931.69 | 821.69 |
| EV / Net Operating Revenue (X) | 1.25 | 1.46 | 0.86 | 0.80 | 1.08 |
| EV / EBITDA (X) | 15.73 | 14.88 | 8.15 | 10.07 | 9.34 |
| MarketCap / Net Operating Revenue (X) | 1.00 | 1.24 | 0.63 | 0.51 | 0.55 |
| Price / BV (X) | 2.21 | 3.12 | 1.57 | 1.41 | 1.12 |
| Price / Net Operating Revenue (X) | 1.00 | 1.24 | 0.63 | 0.51 | 0.55 |
| EarningsYield | 0.02 | 0.03 | 0.03 | 0.07 | -0.13 |
After reviewing the key financial ratios for BL Kashyap & Sons Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 5. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 5. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.77. This value is below the healthy minimum of 3. It has decreased from 2.79 (Mar 24) to 1.77, marking a decrease of 1.02.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 23.23. It has increased from 22.02 (Mar 24) to 23.23, marking an increase of 1.21.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 23.23. It has increased from 22.02 (Mar 24) to 23.23, marking an increase of 1.21.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 51.17. It has decreased from 55.20 (Mar 24) to 51.17, marking a decrease of 4.03.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 4.06. This value is within the healthy range. It has decreased from 5.43 (Mar 24) to 4.06, marking a decrease of 1.37.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.51. This value is within the healthy range. It has decreased from 4.97 (Mar 24) to 3.51, marking a decrease of 1.46.
- For PBT / Share (Rs.), as of Mar 25, the value is 2.23. This value is within the healthy range. It has decreased from 2.81 (Mar 24) to 2.23, marking a decrease of 0.58.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 2. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 2. It has decreased from 2.33 (Mar 24) to 1.22, marking a decrease of 1.11.
- For PBDIT Margin (%), as of Mar 25, the value is 7.92. This value is below the healthy minimum of 10. It has decreased from 9.84 (Mar 24) to 7.92, marking a decrease of 1.92.
- For PBIT Margin (%), as of Mar 25, the value is 6.85. This value is below the healthy minimum of 10. It has decreased from 9.00 (Mar 24) to 6.85, marking a decrease of 2.15.
- For PBT Margin (%), as of Mar 25, the value is 4.35. This value is below the healthy minimum of 10. It has decreased from 5.08 (Mar 24) to 4.35, marking a decrease of 0.73.
- For Net Profit Margin (%), as of Mar 25, the value is 2.38. This value is below the healthy minimum of 5. It has decreased from 4.22 (Mar 24) to 2.38, marking a decrease of 1.84.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.38. This value is below the healthy minimum of 8. It has decreased from 4.22 (Mar 24) to 2.38, marking a decrease of 1.84.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.24. This value is below the healthy minimum of 15. It has decreased from 10.58 (Mar 24) to 5.24, marking a decrease of 5.34.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.60. This value is within the healthy range. It has decreased from 17.16 (Mar 24) to 11.60, marking a decrease of 5.56.
- For Return On Assets (%), as of Mar 25, the value is 1.81. This value is below the healthy minimum of 5. It has decreased from 3.72 (Mar 24) to 1.81, marking a decrease of 1.91.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.07. This value is below the healthy minimum of 0.2. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.60. This value is within the healthy range. It has decreased from 0.62 (Mar 24) to 0.60, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.78. It has decreased from 0.91 (Mar 24) to 0.78, marking a decrease of 0.13.
- For Current Ratio (X), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 1.5. It has increased from 1.37 (Mar 24) to 1.40, marking an increase of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 1.17. This value is within the healthy range. It has increased from 0.71 (Mar 24) to 1.17, marking an increase of 0.46.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 4. It has increased from 1.57 (Mar 24) to 1.59, marking an increase of 0.02.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.93. This value is below the healthy minimum of 3. It has decreased from 2.51 (Mar 24) to 1.93, marking a decrease of 0.58.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 3. It has decreased from 2.08 (Mar 24) to 1.19, marking a decrease of 0.89.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,439.17. It has decreased from 1,822.80 (Mar 24) to 1,439.17, marking a decrease of 383.63.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.25. This value is within the healthy range. It has decreased from 1.46 (Mar 24) to 1.25, marking a decrease of 0.21.
- For EV / EBITDA (X), as of Mar 25, the value is 15.73. This value exceeds the healthy maximum of 15. It has increased from 14.88 (Mar 24) to 15.73, marking an increase of 0.85.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 1.24 (Mar 24) to 1.00, marking a decrease of 0.24.
- For Price / BV (X), as of Mar 25, the value is 2.21. This value is within the healthy range. It has decreased from 3.12 (Mar 24) to 2.21, marking a decrease of 0.91.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 1.24 (Mar 24) to 1.00, marking a decrease of 0.24.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in BL Kashyap & Sons Ltd:
- Net Profit Margin: 2.38%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.6% (Industry Average ROCE: 16.62%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.24% (Industry Average ROE: 21.24%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.19
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.17
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 82.38)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.6
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.38%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Construction, Contracting & Engineering | 409, 4th Floor, New Delhi Delhi 110025 | info@blkashyap.com http://www.blkashyap.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vinod Kashyap | Chairman |
| Mr. Vineet Kashyap | Managing Director |
| Mr. Vikram Kashyap | Joint Managing Director |
| Mr. H N Nanani | Independent Director |
| Ms. Poonam Sangha | Independent Director |
| Mr. Vivek Talwar | Independent Director |
| Mr. Settihalli Basavaraj | Independent Director |
| Mr. Vishal Sharat Ohri | Nominee Director |